English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis Journal article
Wu, Hao Xiang, Pan, Yi Qian, He, Ye, Wang, Zi Xian, Guan, Wen Long, Chen, Yan Xing, Yao, Yi Chen, Shao, Ning Yi, Xu, Rui Hua, Wang, Feng. Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis[J]. Journal of Clinical Oncology, 2023, 41(9), 1735-1746.
Authors:  Wu, Hao Xiang;  Pan, Yi Qian;  He, Ye;  Wang, Zi Xian;  Guan, Wen Long; et al.
Favorite | TC[WOS]:30 TC[Scopus]:32  IF:42.1/37.4 | Submit date：2023/04/03
Pembrolizumab  Placebo  Camrelizumab  Nivolumab  Survival  Efficacy  Therapy  Safety  Chemo  
MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer Journal article
Fan,Jiansong, Zhang,Lei, Lv,Tianxu, Liu,Yuan, Sun,Heng, Miao,Kai, Jiang,Chunjuan, Li,Lihua, Pan,Xiang. MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149(11), 9229-9241.
Authors:  Fan,Jiansong;  Zhang,Lei;  Lv,Tianxu;  Liu,Yuan;  Sun,Heng; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:2.7/3.1 | Submit date：2023/08/03
Ancillary Diagnosis  Artificial Intelligence  Digital Pathology  Lymph Node And Distant Metastasis  Primary Breast Cancer  
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Journal article
Chen, Yu Chi, Shi, Wei, Shi, Jia Jie, Lu, Jin Jian. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148(1), 1-14.
Authors:  Chen, Yu Chi;  Shi, Wei;  Shi, Jia Jie;  Lu, Jin Jian
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:2.7/3.1 | Submit date：2022/02/21
Anemia  Cd47/sirpα  Immunotherapy  Macrophages  Phagocytosis Checkpoint  
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:  Yuxin Zhao;  Haiyong Wang;  Chengwei He
Favorite | TC[WOS]:20 TC[Scopus]:19  IF:2.7/3.1 | Submit date：2021/12/08
Non-small Cell Lung Cancer  Targeted Therapy  Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor  Drug Resistance  
Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: A multi-institutional prospective study Journal article
Aggarwal R., Huang J., Alumkal J.J., Zhang L., Feng F.Y., Thomas G.V., Weinstein A.S., Friedl V., Zhang C., Witte O.N., Lloyd P., Gleave M., Evans C.P., Youngren J., Beer T.M., Rettig M., Wong C.K., True L., Foye A., Playdle D., Ryan C.J., Lara P., Chi K.N., Uzunangelov V., Sokolov A., Newton Y., Beltran H., Demichelis F., Rubin M.A., Stuart J.M., Small E.J.. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: A multi-institutional prospective study[J]. Journal of Clinical Oncology, 2018, 36(24), 2492-2503.
Authors:  Aggarwal R.;  Huang J.;  Alumkal J.J.;  Zhang L.;  Feng F.Y.; et al.
Favorite | TC[WOS]:498 TC[Scopus]:504 | Submit date：2019/01/16
Distribution and localization of microfilament cytoskeleton is regulated by EBP50 Journal article
Liu K., Zheng J., Wang Y., Chen P., He J.. Distribution and localization of microfilament cytoskeleton is regulated by EBP50[J]. Chinese-German Journal of Clinical Oncology, 2009, 8(5), 282-285.
Authors:  Liu K.;  Zheng J.;  Wang Y.;  Chen P.;  He J.
Favorite | TC[Scopus]:0 | Submit date：2019/01/16
Ebp50  Helacell  Microfilament Cytoskeleton  
EBP50 influences distribution and localization of microfilament cytoskeleton in cultured HeLa cells Journal article
Zheng J., Wang Y., Chen P., He J.. EBP50 influences distribution and localization of microfilament cytoskeleton in cultured HeLa cells[J]. Chinese Journal of Clinical Oncology, 2008, 35(20), 1192-1195.
Authors:  Zheng J.;  Wang Y.;  Chen P.;  He J.
Favorite |  | Submit date：2019/01/16
EBP50  HeLa cell  Microfilament cytoskeleton